Direct-Acting Oral Anticoagulant Dabigatran as a Bridging Therapy while Optimizing Warfarin Dosage for Cardioembolic Stroke

Direct-Acting Oral Anticoagulant Dabigatran as a Bridging Therapy while Optimizing Warfarin Dosage for Cardioembolic Stroke

Introduction: Parenteral heparin is widely used as bridging therapy while optimizing oral anticoagulation (OAC). Newer direct-acting OACs (DOACs) attain therapeutic effect very quickly. We report the use of dabigatran as bridging therapy during warfarin optimization for cardioembolic stro...

Full description

Saved in:
Bibliographic Details
Main Authors: Narayanaswamy Venketasubramanian, Yohanna Kusuma, Leonard Leong Litt Yeo, Bernard Chan
Format: Article
Language:English
Published: Karger Publishers 2024-12-01
Series:Cerebrovascular Diseases Extra
Online Access:https://karger.com/article/doi/10.1159/000543301
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items